Skip to the page

Data / Drug companies / Pharma Source Direct, LLC.

Pharma Source Direct, LLC.: 64 products in the FDA NDC directory, labeler code 82393

Pharma Source Direct, LLC. (labeler code 82393) lists 64 products in the FDA National Drug Code Directory. By type: 64 bulk ingredients. Its main marketing category is bulk ingredients. The newest product started marketing on September 1, 2026.

SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.

Labeler code
82393
Products in commercial distribution
64
Packages
358
Finished drugs by generic name
0
Prescription products
0
Over the counter products
0
Controlled substance products
Schedule II 8, Schedule III 11, Schedule IV 2
Started marketing in the last 12 months
2
Earliest marketing start
February 1, 2021
openFDA record search
api.fda.gov

Products by marketing category

Share of the company's products in commercial distribution.

Marketing categoryProductsShare
Bulk ingredients4976.6%
Bulk ingredients for compounding1523.4%

Products by type

TypeProductsShare
Bulk ingredients64100%

Dosage forms

Dosage formProductsShare
Powder64100%

Newest products

By marketing start date.

ProductProduct NDCDosage formMarketing categoryMarketing start
Testosterone propionate82393-603PowderBulk ingredientsSeptember 1, 2026
Testosterone enanthate82393-601PowderBulk ingredientsMarch 1, 2026
Rocuronium bromide82393-510PowderBulk ingredientsNovember 1, 2025
Beta-nicotinamide adenine dinucleotide82393-509PowderBulk ingredients for compoundingOctober 1, 2025
Nicotinamide adenine dinucleotide82393-508PowderBulk ingredientsAugust 1, 2025
Sermorelin acetate82393-507PowderBulk ingredientsJuly 1, 2025
Nandrolone decanoate82393-506PowderBulk ingredientsJuly 1, 2025
Testosterone undecanoate82393-505PowderBulk ingredientsJuly 1, 2025
Enclomiphene citrate82393-504PowderBulk ingredientsApril 1, 2025
Stanozolol82393-503PowderBulk ingredientsApril 1, 2025
Desmopressin acetate (trihydrate)82393-502PowderBulk ingredientsApril 1, 2025
Sirolimus (rapamycin)82393-501PowderBulk ingredientsJanuary 1, 2025
Ropivacaine hcl (monohydrate)82393-409PowderBulk ingredientsJanuary 1, 2025
Phentolamine mesylate82393-408PowderBulk ingredientsOctober 1, 2024
Tirzepatide82393-407PowderBulk ingredientsJuly 1, 2024
Semaglutide82393-406PowderBulk ingredientsJuly 1, 2024
Naltrexone hcl (anhydrous)82393-405PowderBulk ingredientsMarch 1, 2024
Naltrexone hcl (anhydrous) (micronized)82393-404PowderBulk ingredientsMarch 1, 2024
Hydrocortisone (micronized)82393-403PowderBulk ingredientsMarch 1, 2024
Papaverine hcl82393-402PowderBulk ingredientsMarch 1, 2024
Dutasteride82393-401PowderBulk ingredientsJanuary 1, 2024
Minoxidil82393-311PowderBulk ingredientsNovember 1, 2023
Modafinil82393-310PowderBulk ingredientsNovember 1, 2023
Clomiphene citrate82393-309PowderBulk ingredientsNovember 1, 2023
Oxandrolone82393-308PowderBulk ingredientsOctober 1, 2023

Updated November 6, 2026. Read from US Food and Drug Administration, National Drug Code Directory (openFDA). CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.